Results 251 to 260 of about 187,124 (359)

JAK Inhibitors in Psoriatic–Atopic Dermatitis Overlap: A Four‑Case Series

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Overlap between psoriasis and atopic dermatitis (AD) poses diagnostic and therapeutic challenges; monoclonal antibodies targeting a single axis may improve one component while worsening the other [1]. Janus kinase (JAK) inhibitors act pleiotropically and may provide simultaneous control of psoriatic and eczematous inflammation [2].
Eleonora Bongiovanni   +6 more
wiley   +1 more source

Th17 Down-regulation Is Involved in Reduced Progression of Schistosomiasis Fibrosis in ICOSL KO Mice

open access: gold, 2015
Bo Wang   +7 more
openalex   +2 more sources

When worlds collide: Th17 and Treg cells in cancer and autoimmunity

open access: yesCellular & Molecular Immunology, 2018
H. Knochelmann   +6 more
semanticscholar   +1 more source

Aiolos and Eos drive distinct human TH17 functional states. [PDF]

open access: yesCell Mol Life Sci
Cerboni S   +32 more
europepmc   +1 more source

Paradoxical Alopecia Areata Induced by IL‐17 and IL‐23 Inhibitors: A Systematic Review

open access: yesJEADV Clinical Practice, EarlyView.
This systematic review identifies consistent clinical patterns of alopecia areata associated with IL‐17 and IL‐23 inhibitors, most frequently involving secukinumab and ustekinumab. Disease severity varied widely, and management often required biologic discontinuation or therapeutic switching.
Isabella Kamholtz   +2 more
wiley   +1 more source

Candidalysin promotes fungal-specific Th17 CD4 T cell differentiation and protective systemic immunogenicity. [PDF]

open access: yesMucosal Immunol
Nguyen NNM   +6 more
europepmc   +1 more source

Th17/treg balance in Inflammatory Bowel Disease: the role of microbial, and genetic regulators in disease modulation. [PDF]

open access: yesFront Cell Dev Biol
Giudice A   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy